Skip to main content
Top
Published in: Tobacco Induced Diseases 3/2003

Open Access 01-09-2003 | Research

Impact of Smoking Reduction on Coronary Heart Disease Mortality Trends During 1981–2000 in England and Wales

Authors: B Unal, JA Critchley, S Capewell

Published in: Tobacco Induced Diseases | Issue 3/2003

Login to get access

Abstract

Objective

To explore how much of the coronary heart disease (CHD) mortality fall in England and Wales can be attributed to changes in smoking prevalence.

Methods

A previously validated cell-based IMPACT CHD mortality model was used to estimate the deaths prevented or postponed by changes in population smoking prevalence in England and Wales between 1981 and 2000. CHD mortality statistics and population trends in smoking were obtained from routine data sources.

Results

In England and Wales between 1981 and 2000, smoking prevalence in adults aged 25–84 decreased from 43% to 28% in men and from 35% to 24% in women. In men, most of the decrease occurred in those aged over 55. Smoking prevalence changed little in older women. An estimated 29,460 deaths were prevented or postponed (DPP) by this population reduction in smoking prevalence. Most of this benefit was seen in men (86% of the DPPs versus 14% in women).

Conclusion

Large declines in smoking prevalence accounted for 29,460 fewer CHD deaths in England and Wales in 2000 compared with 1981. This emphasises the importance of a national strategy with comprehensive tobacco control programmes to further reduce smoking.
Literature
1.
go back to reference Kuulasmaa K, Tunstall PH, Dobson AJ, et al: Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project. Lancet. 2000, 355: 675-87. 10.1016/S0140-6736(99)11180-2.CrossRefPubMed Kuulasmaa K, Tunstall PH, Dobson AJ, et al: Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project. Lancet. 2000, 355: 675-87. 10.1016/S0140-6736(99)11180-2.CrossRefPubMed
2.
go back to reference Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P: Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ. 1994, 309: 23-7.PubMedCentralCrossRefPubMed Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilahti P: Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ. 1994, 309: 23-7.PubMedCentralCrossRefPubMed
3.
go back to reference Jackson R, Stewart A, Beaglehole R: Trends in coronary heart disease mortality and morbidity in Auckland, New Zealand, 1974–1986. Int J Epidemiol. 1990, 19: 279-83. 10.1093/ije/19.2.279.CrossRefPubMed Jackson R, Stewart A, Beaglehole R: Trends in coronary heart disease mortality and morbidity in Auckland, New Zealand, 1974–1986. Int J Epidemiol. 1990, 19: 279-83. 10.1093/ije/19.2.279.CrossRefPubMed
4.
go back to reference Sigfusson N, Sigvaldson H, Steingrimsdottir L, et al: Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ. 1991, 302: 1371-5. 10.1136/bmj.302.6789.1371.PubMedCentralCrossRefPubMed Sigfusson N, Sigvaldson H, Steingrimsdottir L, et al: Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ. 1991, 302: 1371-5. 10.1136/bmj.302.6789.1371.PubMedCentralCrossRefPubMed
5.
go back to reference Sackett DL: Evidence-based medicine and treatment choices. Lancet. 1997, 349: 570-3. 10.1016/S0140-6736(97)80122-5.CrossRefPubMed Sackett DL: Evidence-based medicine and treatment choices. Lancet. 1997, 349: 570-3. 10.1016/S0140-6736(97)80122-5.CrossRefPubMed
6.
go back to reference McGovern PG, Pankow JS, Shahar E, et al: Recent trends in acute coronary heart disease mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med. 1996, 334: 884-90. 10.1056/NEJM199604043341403.CrossRefPubMed McGovern PG, Pankow JS, Shahar E, et al: Recent trends in acute coronary heart disease mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med. 1996, 334: 884-90. 10.1056/NEJM199604043341403.CrossRefPubMed
8.
go back to reference Isles CG, Hole DJ, Hawthorne VM, Lever AF: Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet. 1992, 339: 702-6. 10.1016/0140-6736(92)90599-X.CrossRefPubMed Isles CG, Hole DJ, Hawthorne VM, Lever AF: Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey: comparison with men. Lancet. 1992, 339: 702-6. 10.1016/0140-6736(92)90599-X.CrossRefPubMed
9.
go back to reference U.S. Department of Health and Human Services: Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. 1989, Rockville, Maryland: DHHS Publication No. (CDC), 89-8411. U.S. Department of Health and Human Services: Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. 1989, Rockville, Maryland: DHHS Publication No. (CDC), 89-8411.
10.
go back to reference Jousilahti P, Vartiainen E, Tuomilehto J, Puska P: Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999, 99: 1165-72.CrossRefPubMed Jousilahti P, Vartiainen E, Tuomilehto J, Puska P: Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999, 99: 1165-72.CrossRefPubMed
11.
go back to reference Bottcher M, Falk E: Pathology of the coronary arteries in smokers and non-smokers. J Cardiovasc Risk. 1999, 6: 299-302.PubMed Bottcher M, Falk E: Pathology of the coronary arteries in smokers and non-smokers. J Cardiovasc Risk. 1999, 6: 299-302.PubMed
12.
go back to reference Powell JT: Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med. 1998, 3: 21-8.CrossRefPubMed Powell JT: Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med. 1998, 3: 21-8.CrossRefPubMed
13.
go back to reference U.S. Department of Health and Human Services: The Surgeon General's 1990 Report on the Health Benefits of Smoking Cessation. 1990, Rockville, Maryland: DHHS Publication No. (CDC), 89-8411. U.S. Department of Health and Human Services: The Surgeon General's 1990 Report on the Health Benefits of Smoking Cessation. 1990, Rockville, Maryland: DHHS Publication No. (CDC), 89-8411.
14.
go back to reference Buck D: GCPSRM, University of York Centre for Health Economics. Cost effectiveness of smoking cessation interventions. 1997, London: Health Education Authority Buck D: GCPSRM, University of York Centre for Health Economics. Cost effectiveness of smoking cessation interventions. 1997, London: Health Education Authority
15.
go back to reference Smoking Kills: A White Paper on Tobacco. 1998, London, Stationery Office Smoking Kills: A White Paper on Tobacco. 1998, London, Stationery Office
16.
go back to reference Capewell S, Morrison CE, McMurray JJ: Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999, 81: 380-6.PubMedCentralCrossRefPubMed Capewell S, Morrison CE, McMurray JJ: Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999, 81: 380-6.PubMedCentralCrossRefPubMed
17.
go back to reference Capewell S, Beaglehole R, Seddon M, McMurray J: Explaining the decline in Coronary Heart Disease Mortality in Auckland, New Zealand between 1982 and 1993. Circulation. 2000, 102: 1511-6.CrossRefPubMed Capewell S, Beaglehole R, Seddon M, McMurray J: Explaining the decline in Coronary Heart Disease Mortality in Auckland, New Zealand between 1982 and 1993. Circulation. 2000, 102: 1511-6.CrossRefPubMed
18.
go back to reference ONS-Office for National Statistics: Population:Age and sex, 1971 onwards. Health Statistics Quarterly. 2001, 11. ONS-Office for National Statistics: Population:Age and sex, 1971 onwards. Health Statistics Quarterly. 2001, 11.
19.
go back to reference ONS-Office for National Statistics: Mortality Statistics cause. Review of the Registrar General on deaths by cause, sex and age, in England and Wales, 1999. 2000, London, Stationery Office ONS-Office for National Statistics: Mortality Statistics cause. Review of the Registrar General on deaths by cause, sex and age, in England and Wales, 1999. 2000, London, Stationery Office
20.
go back to reference Shaper AG, Pocock SJ, Walker M, et al: British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ. 1981, 283: 179-86. 10.1136/bmj.283.6285.179.PubMedCentralCrossRefPubMed Shaper AG, Pocock SJ, Walker M, et al: British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ. 1981, 283: 179-86. 10.1136/bmj.283.6285.179.PubMedCentralCrossRefPubMed
21.
go back to reference ONS-Office for National Statistics-Social Survey Division: General Household Survey 1980. 1982, London: Stationery Office ONS-Office for National Statistics-Social Survey Division: General Household Survey 1980. 1982, London: Stationery Office
22.
go back to reference Erens B, Primatesta P: Health Survey for England. Cardiovascular Disease '98. 1999, London: Stationery Office Erens B, Primatesta P: Health Survey for England. Cardiovascular Disease '98. 1999, London: Stationery Office
23.
go back to reference ONS-Office for National Statistics Social Survey Division: Living in Britain:Results from the 2000/01 General Household Survey. 2001, London: The Stationery Office ONS-Office for National Statistics Social Survey Division: Living in Britain:Results from the 2000/01 General Household Survey. 2001, London: The Stationery Office
24.
go back to reference Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002, 324: 71-86. 10.1136/bmj.324.7329.71. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002, 324: 71-86. 10.1136/bmj.324.7329.71.
25.
go back to reference Ryan R, Majeed A: Prevalence of ischaemic heart disease and its management with statins and aspirin in general practice in England and Wales, 1994–98. Health Statistics Quarterly. 2001, 12: 34-9. Ryan R, Majeed A: Prevalence of ischaemic heart disease and its management with statins and aspirin in general practice in England and Wales, 1994–98. Health Statistics Quarterly. 2001, 12: 34-9.
26.
go back to reference Capewell S, Livingston BM, MacIntyre K, et al: Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J. 2000, 21: 1833-40. 10.1053/euhj.2000.2318.CrossRefPubMed Capewell S, Livingston BM, MacIntyre K, et al: Trends in case-fatality in 117 718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J. 2000, 21: 1833-40. 10.1053/euhj.2000.2318.CrossRefPubMed
Metadata
Title
Impact of Smoking Reduction on Coronary Heart Disease Mortality Trends During 1981–2000 in England and Wales
Authors
B Unal
JA Critchley
S Capewell
Publication date
01-09-2003
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 3/2003
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/1617-9625-1-3-185

Other articles of this Issue 3/2003

Tobacco Induced Diseases 3/2003 Go to the issue